HIV/AIDS in Asia

Lancet

Volumn 364, Issue 9428, 2004, Pages 69-82

  Ruxrungtham, Kiat ^a   Brown, Tim ^b   Phanuphak, Praphan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEVIRAPINE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASIA; CAMBODIA; CHINA; CLINICAL TRIAL; CONDOM; CONFERENCE PAPER; DRUG USE; EPIDEMIC; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERSENSITIVITY; INDONESIA; LACTIC ACIDOSIS; PRIORITY JOURNAL; PROSTITUTION; SEX RATIO; SEXUAL EDUCATION; SEXUAL TRANSMISSION; SIDE EFFECT; STEVENS JOHNSON SYNDROME; THAILAND; VIET NAM; VIRUS TRANSMISSION; AIDS RELATED COMPLEX; DISEASE TRANSMISSION; EPIDEMIOLOGY; PREVALENCE; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; DISEASE OUTBREAKS; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 3042701084     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16593-8     Document Type: Conference Paper

References (175)

1. Phanuphak P, Locharernkul C, Panmuong W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol. 3:1985;195-199
2. Brown T, Sittitrai W, Vanichseni S, Thisyakorn U. The recent epidemiology of HIV and AIDS in Thailand. AIDS 1994; 8 (suppl): 131-41.
3. Dore GJ, Kaldor JM, Ungchusak K, Mertens TE. Epidemiology of HIV and AIDS in the Asia-Pacific region. Med J Aust. 165:1996;494-498
4. Dore GJ, Brown T, Tarantola D, Kaldor JM. HIV and AIDS in the Asia-Pacific region: an epidemiological overview. AIDS 1998; 12 (suppl): 1-10.
5. UNAIDS. Report on the global HIV/AIDS epidemic. 2002;UNAIDS, Geneva
6. Estebanez P, Fitch K, Najera R. HIV and female sex workers. Bull World Health Organ. 71:1993;397-412
7. Mertens TE, Low-Beer D. HIV and AIDS: where is the epidemic going? Bull World Health Organ. 74:1996;121-129
8. Crofts N, Reid G, Deany P. Injecting drug use and HIV infection in Asia. AIDS 1998; 12 (suppl): 69-78.
9. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5 (suppl): 71-85.
10. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 14:2000;75-83
11. Newmann S, Sarin P, Kumarasamy N, et al. Marriage, monogamy and HIV: a profile of HIV-infected women in south India. Int J STD AIDS. 11:2000;250-253
12. Xu F, Kilmarx PH, Supawitkul S, et al. HIV-1 seroprevalence, risk factors, and preventive behaviors among women in northern Thailand. J Acquir Immune Defic Syndr. 25:2000;353-359
13. Chan R, Kavi AR, Carl G, et al. HIV and men who have sex with men: perspectives from selected Asian countries. AIDS 1998; 12 (suppl): 59-68.
14. Miyazaki M, Naemura M. Epidemiological characteristics on human immunodeficiency virus infection and acquired immunodeficiency syndrome in Japan. Int J STD AIDS. 5:1994;273-278
15. Chen MY, Wang GR, Chuang CY, Shih YT. Human immunodeficiency virus infection in Taiwan, 1984 to 1994. J Formos Med Assoc. 93:1994;901-905
16. Oh MD, Choe K. Epidemiology of HIV infection in the Republic of Korea. J Korean Med Sci. 14:1999;469-474
17. Pisani E, Girault P, Gultom M, et al. HIV, syphilis infection and sexual practices among transgenders, male sex workers and other men who have sex with men in Jakarta, Indonesia. Sex Transm Infect (in press).
18. Girault P, Saidel T, Song N, et al. HIV, STIs, and sexual behaviors among men who have sex with men in Phnom Penh, Cambodia. AIDS Educ Prev. 16:2004;31-44
19. Colby DJ. HIV knowledge and risk factors among men who have sex with men in Ho Chi Minh City, Vietnam. J Acquir Immune Defic Syndr. 32:2003;80-85
20. Choi KH, Liu H, Guo Y, Han L, Mandel JS, Rutherford GW. Emerging HIV-1 epidemic in China in men who have sex with men. Lancet. 361:2003;2125-2126
21. Joesoef MR, Gultom M, Irana ID, et al. High rates of sexually transmitted diseases among male transvestites in Jakarta, Indonesia. Int J STD AIDS. 14:2003;609-613
22. Sun X, Nan J, Guo Q. AIDS and HIV infection in China. AIDS 1994; 8 (suppl): 55-59.
23. Lin P, Xu R, Zeng C. [Trend and characteristics of HIV/AIDS epidemic in Guangdong province, 1986-1999]. Zhonghua Liu Xing Bing Xue Za Zhi. 22:2001;194-197
24. Lindan CP, Lieu TX, Giang LT, et al. Rising HIV infection rates in Ho Chi Minh City herald emerging AIDS epidemic in Vietnam. AIDS 1997; 11 (suppl): 5-13.
25. Ghys PD, Saidel T, Vu HT, et al. Growing in silence: selected regions and countries with expanding HIV/AIDS epidemics. AIDS 2003; 17 (suppl): 45-50.
26. Family Health International. What drives HIV in Asia? a summary of trends in sexual and drug-taking behaviours. 2001;Family Health International, Arlington
27. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2:2004;33-42
28. Vernazza PL, Kashuba ADM, Cohen MS. Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health. Rev Med Microbiol. 12:2001;131-142
29. Brown T, Sittitrai W. Heterosexual risk behaviors in Asia: the implication for HIV/AIDS. Curr Sci. 69:1995;840-848
30. Parish WL, Laumann EO, Cohen MS, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA. 289:2003;1265-1273
31. Sittitrai W, Phanuphak P, Barry J, Brown T. A survey of Thai sexual behaviour and risk of HIV infection [letter]. Int J STD AIDS. 5:1994;377-378
32. UNAIDS. Relationship of HIV and STD declines in Thailand to behavior change-A synthesis of existing studies. 1998;UNAIDS Key Materials Publication
33. Mills S, Ungchusak K, Srinivasan V, Utomo B, Bennett A. Assessing trends in HIV risk behaviors in Asia. AIDS. 12 (suppl):1998;79-86
34. Chin J, Bennett A, Mills S. Primary determinants of HIV prevalence in Asian-Pacific countries. AIDS 1998; 12 (suppl): 87-91.
35. Brown T, Peerapatanapokin W. The Asian epidemic model: a process model for exploring HIV policy and program alternatives in Asia. Sex Transm Infect (in press).
36. Saidel TJ, Des Jarlais D, Peerapatanapokin W, Dorabjee J, Singh S, Brown T. Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian Epidemic Model. Int J Drug Policy. 14:2003;63-74
37. Cambodian Working Group on HIV/AIDS Projection. Projections for HIV/AIDS in Cambodia: 2000-2010. 2002;National Center for HIV/AIDS, Dermatology and STD, Phnom Penh
38. Thai Working Group on HIV/AIDS Projection. Projections for HIV/AIDS in Thailand: 2000-2020. 2001;Division of AIDS, Ministry of Public Health, Bangkok
39. Gorbach PM, Sopheab H, Phalla T, et al. Sexual bridging by Cambodian men: potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis. 27:2000;320-326
40. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet. 344:1994;243-245
41. Hanenberg R, Rojanapithayakorn W. Changes in prostitution and the AIDS epidemic in Thailand. AIDS Care. 10:1998;69-79
42. National AIDS/STD Programme. HIV in Bangladesh: is time running out? 2003;Ministry of Health and Welfare, Dhaka
43. Pisani E, Garnett GP, Grassly NC, et al. Back to basics in HIV prevention: focus on exposure. BMJ. 326:2003;1384-1387
44. Brown T, Franklin B, MaNeil J, Mills S. Effective prevention strategies in low HIV prevalence settings. 2001;Family Health International, Bangkok
45. Ainsworth M, Beyrer C, Soucat A. AIDS and public policy: the lessons and challenges of "success" in Thailand. Health Policy. 64:2003;13-37
46. Ainsworth M. Setting government priorities in preventing HIV/AIDS. Finance Dev 1998: 18-21.
47. WHO. Treating 3 million by 2005: making it happen - the WHO strategy. 2003;World Health Organization, Geneva
48. Kumarasamy N, Solomon S, Chaguturu SK, et al. The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 17:2003;2267-2269
49. Dickson D. Indian company offers cheap anti-AIDS drugs. Nature. 409:2001;751
50. Elliott R. China: government issues licences for three antiretrovirals. Can HIV AIDS Policy Law Rev. 7:2002;61
51. Burger D, Boyd M, Duncombe C, et al. Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients. J Antimicrob Chemother. 51:2003;1231-1238
52. Cardiello PG, Samor T, Burger D, et al. Pharmacokinetics of lower doses of saquinavir soft-gel caps (800 and 1200 mg twice daily) boosted with itraconazole in HIV-1-positive patients. Antivir Ther. 8:2003;245-249
53. Boyd MA, Aarnoutse RE, Ruxrungtham K, et al. Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects. J Acquir Immune Defic Syndr. 34:2003;134-139
54. Pan PP. Some Chinese with AIDS abandon free 'cocktail'; emergence of drug-resistant strains feared. Washington Post Nov 11, 2003.
55. Wagner MD. National leadership, international cooperation keys to effective AIDS response. IAPAC Monthly. 9:2003;320-329
56. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 29:2002;184-190
57. Sahni AK, Prasad VV, Seth P. Genomic diversity of human immunodeficiency virus type-1 in India. Int J STD AIDS. 13:2002;115-118
58. Weniger BG, Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8 (suppl): 13-28.
59. Lan NT, Recordon-Pinson P, Hung PV, et al. HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. AIDS Res Hum Retroviruses. 19:2003;925-928
60. Menu E, Reynes JM, Muller-Trutwin MC, et al. Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. J Acquir Immune Defic Syndr Hum Retrovirol. 20:1999;481-487
61. Takebe Y, Motomura K, Tatsumi M, Lwin HH, Zaw M, Kusagawa S. High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination. AIDS. 17:2003;2077-2087
62. Paladin FJ, Monzon OT, Tsuchie H, Aplasca MR, Learn GH Jr, Kurimura T. Genetic subtypes of HIV-1 in the Philippines. AIDS. 12:1998;291-300
63. Santiago ML, Santiago EG, Hafalla JC, et al. Molecular epidemiology of HIV-1 infection in the Philippines, 1985 to 1997: transmission of subtypes B and E and potential emergence of subtypes C and F. J Acquir Immune Defic Syndr Hum Retrovirol. 18:1998;260-269
64. Lee CN, Wang WK, Fan WS, et al. Determination of human immunodeficiency virus type 1 subtypes in Taiwan by vpu gene analysis. J Clin Microbiol. 38:2000;2468-2474
65. Chen YM, Huang KL, Jen I, et al. Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998. J Acquir Immune Defic Syndr. 26:2001;274-282
66. Yang R, Kusagawa S, Zhang C, Xia X, Ben K, Takebe Y. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol. 77:2003;685-695
67. Yu XF, Wang X, Mao P, et al. Characterization of HIV type 1 heterosexual transmission in Yunnan, China. AIDS Res Hum Retroviruses. 19:2003;1051-1055
68. Su B, Liu L, Wang F, et al. HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS. 17:2003;2515-2520
69. Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol. 74:2000;11286-11295
70. Suligoi B, Galli C, Massi M, et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol. 40:2002;4015-4020
71. Chen J, Wang L, Chen JJ, et al. Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection. J Infect Dis. 186:2002;321-331
72. Anonymous. New testing strategy to help track HIV. Detuned testing initiated at 24 sentinel sites. AIDS Alert. 18:2003;57-58
73. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 280:1998;42-48
74. Gouws E, Williams BG, Sheppard HW, Enge B, Karim SA. High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr. 29:2002;531-535
75. Dukers NH, Spaargaren J, Geskus RB, Beijnen J, Coutinho RA, Fennema HS. HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections. AIDS. 16:2002;19-24
76. Hu DJ, Vanichseni S, Mock PA, et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses. 19:2003;727-730
77. Ramana GV, Vasanthi A, Khaja M, et al. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India. J Genet. 80:2001;137-140
78. Nookhai S, Ruxrungtham K, Phanuphak P, Oelrichs R. Prevalence of CCR2-64I, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais. Eur J Immunogenet. 27:2000;153-157
79. Yang C, Li M, Limpakarnjanarat K, et al. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand. AIDS Res Hum Retroviruses. 19:2003;661-665
80. Ramamoorti N, Kumarvelu J, Shanmugasundaram GK, Rani K, Banerjea AC. High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 39-untranslated region of SDF-1 RNA. Genes Immun. 2:2001;408-410
81. Truong LX, Luong TT, Scott-Algara D, et al. CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS. 17:2003;1425-1434
82. Shieh B, Yan YP, Ko NY, et al. Detection of elevated serum beta-chemokine levels in seronegative Chinese individuals exposed to human immunodeficiency virus type 1. Clin Infect Dis. 33:2001;273-279
83. Rangsin R, Chiu J, Khamboonruang C, et al. The natural history of HIV-1 infection in young thai men after seroconversion. J Acquir Immune Defic Syndr. 36:2004;622-629
84. Hira SK, Shroff HJ, Lanjewar DN, Dholkia YN, Bhatia VP, Dupont HL. The natural history of human immunodeficiency virus infection among adults in Mumbai. Natl Med J India. 16:2003;126-131
85. Munoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997; 11 (suppl): 69-76.
86. Ruxrungtham K, Phanuphak P. Update on HIV/AIDS in Thailand. J Med Assoc Thai 2001; 84 (suppl): 1-17.
87. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 36:2003;79-85
88. Sirisanthana T. Infection due to Penicillium marneffei. Ann Acad Med Singapore. 26:1997;701-704
89. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 45:2002;268-271
90. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis. 26:1998;1107-1110
91. Suwanagool S, Kolladarungkri T, Leelarasamee A, Chuenarom V, Jearanaisilavong J, Chaiprasert A. Prolonged fever due to Mycobacterium avium complex (MAC) disease in advanced HIV infection: a public health concern. J Med Assoc Thai. 81:1998;893-905
92. Hsieh SM, Hung CC, Chen MY, Hsueh PR, Chang SC, Luh KT. Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan. AIDS. 12:1998;1301-1307
93. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr. 24:2000;378-385
94. Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J Epidemiol Community Health. 49:1995;309-313
95. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 33:2004;182-188
96. Zhang C, Yang R, Xia X, et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr. 29:2002;191-196
97. Kura MM, Hira S, Kohli M, Dalal PJ, Ramnani VK, Jagtap MR. High occurrence of HBV among STD clinic attenders in Bombay, India. Int J STD AIDS. 9:1998;231-233
98. Manjunath JV, Thappa DM, Jaisankar TJ. Sexually transmitted diseases and sexual lifestyles of long-distance truck drivers: a clinico-epidemiologic study in south India. Int J STD AIDS. 13:2002;612-617
99. Risbud A, Mehendale S, Basu S, et al. Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India. Sex Transm Infect. 78:2002;169-173
100. Law WP, Dore GJ, Duncombe CJ, et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001. AIDS. 17:2003;2191-2199
101. Iademarco MF, Castro KG. Epidemiology of tuberculosis. Semin Respir Infect. 18:2003;225-240
102. Ribera E, Pou L, Lopez RM, et al. Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acquir Immune Defic Syndr. 28:2001;450-453
103. Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents: the Department of Health and Human Services (DHHS), 2003.
104. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS. 17:2003;1398-1400
105. Udwadia ZF. India's multidrug-resistant tuberculosis crisis. Ann N Y Acad Sci. 953:2001;98-105
106. Miah MR, Ali MS, Saleh AA, Sattar H. Primary drug resistance pattern of mycobacterium tuberculosis in Dhaka, Bangladesh. Bangladesh Med Res Counc Bull. 26:2000;33-40
107. Yoshiyama T, Supawitkul S, Kunyanone N, et al. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Int J Tuberc Lung Dis. 5:2001;32-39
108. Punnotok J, Shaffer N, Naiwatanakul T, et al. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis. 4:2000;537-543
109. Putong NM, Pitisuttithum P, Supanaranond W, et al. Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes. Southeast Asian J Trop Med Public Health. 33:2002;346-351
110. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS. 17:2003;2129-2131
111. Kunimoto DY, Chui L, Nobert E, Houston S. Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy. Int J Tuberc Lung Dis. 3:1999;944-947
112. WHO. Treatment of tuberculosis: guidelines for national programmes. third edn :2003;World Health Organization, Geneva
113. Sheng WH, Hsieh SM, Lee SC, et al. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan. Int J STD AIDS. 15:2004;249-253
114. Fischl M, Castro J, Monroig R, et al. Impact of directly observed therapy on long-term outcomes in clinical trials (slide session 528). 8th Conference on Retroviruses and Opportunistic Infections 2001, Chicago, IL.
115. Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis. 34:2002;984-990
116. Lurie MN, Carter EJ, Cohen J, Flanigan TP. Directly observed therapy for HIV/tuberculosis co-infection. Lancet Infect Dis. 4:2004;137-138
117. Cardiello PG, van Heeswijk RP, Hassink EA, et al. Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study. J Acquir Immune Defic Syndr. 29:2002;464-470
118. Frater J. The impact of HIV-1 subtype on the clinical response on HAART. J HIV Ther. 7:2002;92-96
119. Sirivichayakul S, Ruxrungtham K, Ungsedhapand C, et al. Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. AIDS. 17:2003;1889-1896
120. Ruxrungtham K, Ubolyam S, Hassink EA, et al. Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy. Asian Pac J Allergy Immunol. 20:2002;105-111
121. WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003;World Health Organization, Geneva
122. Ruxrungtham K, Siangphoe U, Ungsedhaphan C, et al. Total lymphocyte count (TLC) is not a good surrogate marker for monitoring antiretroviral therapy (ART) in HIV-1 infected thai patients: HIVNAT cohort analysis: abstract submitted for the XV International AIDS Conference, Bangkok, 2004.
123. Pattanapanyasat K, Lerdwana S, Shain H, et al. Low-cost CD4 enumeration in HIV-infected patients in Thailand. Asian Pac J Allergy Immunol. 21:2003;105-113
124. Diagbouga S, Chazallon C, Kazatchkine MD, et al. Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS. 17:2003;2201-2208
125. Buranapraditkun S, Sopa B, Nookai S, et al. A novel and simplified non-FACS based CD4+ cell count method in HIV-1 infection: CD4+ magnetic bead depletion with automated cell counting. 11th Conference on Retroviruses and Opportunistic Infections (CROI) 2004, Moscone West, San Francisco, CA.
126. Vajpayee M, Kanswal S, Seth P, Wig N. Spectrum of opportunistic infections and profile of CD4+ counts among AIDS patients in North India. Infection. 31:2003;336-340
127. Anil S, Challacombe SJ. Oral lesions of HIV and AIDS in Asia: an overview. Oral Dis 1997; 3 (suppl): 36-40.
128. Reichart PA, Khongkhunthian P, Bendick C. Oral manifestations in HIV-infected individuals from Thailand and Cambodia. Med Microbiol Immunol (Berl). 192:2003;157-160
129. Anonymous. Thailand markets low-cost, 3-in-1 antiretroviral medication. AIDS Policy Law. 17:2002;8
130. Pollard RB, Robinson P, Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 20:1998;1071-1092
131. Ho TT, Wong KH, Chan KC, Lee SS. High incidence of nevirapine-associated rash in HIV-infected Chinese. AIDS. 12:1998;2082-2083
132. Deng SC, Chen MY, Hsieh SM, et al. Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan. J Microbiol Immunol Infect. 36:2003;10-14
133. Sungkanuparph S, Vibhagool A, Mootsikapun P, et al. Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. J Acquir Immune Defic Syndr. 33:2003;118-119
134. Walker N, Garcia-Calleja JM, Heaton L, et al. Epidemiological analysis of the quality of HIV sero-surveillance in the world: how well do we track the epidemic? AIDS. 15:2001;1545-1554
135. Pisani E, Lazzari S, Walker N, Schwartlander B. HIV surveillance: a global perspective. J Acquir Immune Defic Syndr. 32 (suppl):2003;3-11
136. Phoolcharoen W, Ungchusak K, Sittitrai W, Brown T. Thailand: Lessons from a strong national response to HIV/AIDS. AIDS. 12 (suppl):1998;123-135
137. Phalla T, Leng HB, Mills S, et al. HIV and STD epidemiology, risk behaviors, and prevention and care response in Cambodia. AIDS. 12 (suppl):1998;11-18
138. Khan OA, Hyder AA. Responses to an emerging threat: HIV/AIDS policy in Pakistan. Health Policy Plan. 16:2001;214-218
139. Viravaidya M, Obremskey SA, Myers CM. The economic impact of AIDS on thailand. Bloom DE, Lyons J. Economic implications of AIDS in Asia. New. 1993;7-34 United Nations Development Programme, Delhi
140. Quan VM, Chung A, Long HT, Dondero TJ. HIV in Vietnam: the evolving epidemic and the prevention response, 1996 through 1999. J Acquir Immune Defic Syndr. 25:2000;360-369
141. World Bank. Thailand's response to AIDS - building on success, confronting the future. 2000;The World Bank, Bangkok
142. UNAIDS and AIDS Division Thai Ministry of Public Health. Evaluation of the 100% Condom Programme in Thailand: UNAIDS Case Study. 2000;1-47 Joint United Nations Programme on AIDS and AIDS Division Thai Ministry of Public Health, Geneva
143. Jalal F, Abednego HM, Sadjimin T, Linnan MJ. HIV and AIDS in Indonesia. AIDS. 8 (suppl):1994;91-94
144. Malau C. HIV and development the Papua New Guinea way. Dev Bull. 52:2000;58-60
145. Hyder AA, Khan OA, Shah SA, Memon MA, Khanani MR, Ali S. Sub-national response in HIV/AIDS: a case study in AIDS prevention and control from Sindh province, Pakistan. Public Health. 113:1999;39-43
146. Shao C, Xu W, Ye G. Sexually transmitted disease control in China (1949-1994). Chin Med Sci J. 11:1996;252-257
147. Peters D. PVO/NGO initiatives, Asia. International Voluntary Services, US and Women's Union of Vietnam. AIDSlink. 38:1996;8
148. Elly J, Aisa M, Ananag J, Janet P, Rabia M. Papua New Guinea: an innovative strategy to raise self-esteem of sex workers in Port Moresby, Papua New Guinea and to promote safer sex practices with clients. Pac AIDS Alert Bull. 19:2000;17
149. Phanuphak P, Muller O, Sarangbin S, Sittitrai W. Knowledge, attitudes and behaviour among HIV-positive and HIV-negative clients of a confidential HIV counselling and testing centre in Thailand. AIDS. 8:1994;1315-1319
150. Celentano DD. HIV prevention among drug users: an international perspective from Thailand. J Urban Health. 80:(suppl 3):2003;97-105
151. Weniger BG, Brown T. The march of AIDS through Asia [editorial; comment]. N Engl J Med. 335:1996;343-345
152. Mamtaz A. HIV / AIDS: response to the pandemic in Bangladesh. J Prev Soc Med. 18:1999;74-83
153. Busza J. Literature review: challenging HIV-related stigma and discrimination in southeast Asia - past successes and future priorities. 1999;Population Council Horizons, New York
154. Busza J. Promoting the positive: responses to stigma and discrimination in Southeast Asia. AIDS Care. 13:2001;441-456
155. Kunanusont C, Phoolcharoen W, Bodaramik Y. Evolution of medical services for HIV/AIDS in Thailand. J Med Assoc Thai. 82:1999;425-434
156. Park SW, Kim HB, Choi YJ, Kim NJ, Oh MD, Choe KW. Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy. AIDS Res Hum Retroviruses. 19:2003;1039-1043
157. Muller O, Sarangbin S, Ruxrungtham K, Sittitrai W, Phanuphak P. Sexual risk behaviour reduction associated with voluntary HIV counselling and testing in HIV infected patients in Thailand. AIDS Care. 7:1995;567-572
158. Amornwichet P, Teeraratkul A, Simonds RJ, et al. Preventing mother-to-child HIV transmission: the first year of Thailand's national program. JAMA. 288:2002;245-248
159. Kanshana S, Simonds RJ. National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned. AIDS. 16:2002;953-959
160. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 331:1994;1173-1180
161. Thisyakorn U, Khongphatthanayothin M, Sirivichayakul S, et al. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen. AIDS. 14:2000;2921-2927
162. Phanuphak N, Teerakulpisarn S, Apornpong T, Tasai C, El-Sadr W, Phanuphak P. Parallel MTCT-Plus programs: experiences and lessons learned from Thailand. 11th Conference on Retroviruses and Opportunistic Infections 2004, San Francisco, California.
163. Phanuphak P. Ethical issues in studies in Thailand of the vertical transmission of HIV. N Engl J Med. 338:1998;834-835
164. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 353:1999;773-780
165. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354:1999;795-802
166. Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 15:2001;1951-1957
167. Eshleman SH, Guay LA, Mwatha A, et al. Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012). J Acquir Immune Defic Syndr. 35:2004;126-130
168. Lallemant M, Jourdain G, Le Coeur S, al. e. A randomized, double-blind trial assessing the efficacy of single-dose perinatal nevirapine added to a standard zidovudine regimen for the prevention of mother-to-child transmission of HIV-1 in Thailand. 11th Conference on Retroviruses and Opportunistic Infections 2004, San Francisco, California.
169. Phanuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac J Allergy Immunol. 15:(1):1997;41-48
170. Anonymous. VaxGen announces results of its phase III HIV vaccine trial in Thailand: vaccine fails to meet endpoints.
171. IAVI. IAVI vaccine development fact sheet. Nov 2002.
172. Nitayaphan S, Khamboonruang C, Sirisophana N, et al. A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais. AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences. Vaccine. 18:2000;1448-1455
173. Phanuphak P, Cooper DA, Lange JM. Clinical trials in Asia. AIDS. 12 (suppl):1998;163-167
174. Narain JP. Global Fund to Fight AIDS, TB and Malaria: An update. AIDS Watch (News from WHO South-East Asia Region on STI, HIV and Tuberculosis), 2003: 1-2, 7.
175. United States Bureau of the Census, Population Division, International Programs Center. HIV/AIDS surveillance database. 2003;US Census Bureau, Washington, DC